As with other medicines in the incretin-based drug class, retatrutide is associated with a range of side effects, the majority of which relate to the gastrointestinal system
RETA again led to significant improvements in body composition that were partially retained after RETA withdrawal despite the dramatic weight rebound in the RETA-w/d group
Its primary advantage is weekly dosing, simplifying routine for patients and enhancing adherence
The combination of improving insulin sensitivity and increasing fat metabolism can be especially helpful for those with metabolic issues
Glutathione IV therapy: Strengthens the immune system , helping you fight off colds and infections
Semaglutide is also the first (and so far only) GLP-1 receptor agonist shown to decrease the risk of heart attacks and strokes among people who dont have diabetes, so thats a game changer in the landscape of obesity medicine, Pedersen says